Ultrasound Guided Subclavian Vein Cannulation at Emergency Room
1 other identifier
observational
30
0 countries
N/A
Brief Summary
- 1.To observe and report the success rate associated with the use of ultrasound for subclavian vein catheterization.
- 2.To observe and report the type and complications and any constrains associated with this technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2021
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 25, 2021
CompletedStudy Start
First participant enrolled
November 1, 2021
CompletedFirst Posted
Study publicly available on registry
November 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedNovember 4, 2021
October 1, 2021
3 years
October 25, 2021
October 25, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
success rate of the ultrasound guided subclavian vein cannulation success rate of the ultrasound guided subclavian vein cannulation Success rate of ultrasound guided of subclavian vein cannulation
Use of ultrasound at visualization of cannulation of subclavian vein
Baseline
Interventions
Use of ultrasound at subclavian vein cannulation for visualization
Eligibility Criteria
Any patient has arrived to the emergency room with sign of hypovolemic shock Or arrested
You may qualify if:
- All patient admitted to emergency room and indicated for central venous catheterization
You may not qualify if:
- \. Any contraindication for central vein cannulation as coagulopathy, hemorrhage from target vessel, suspected proximal vascular injury 2- Age below 18 year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Hayashi M, Oshima K. Purification and properties of oxytocinase (cystine amino-peptidase) from monkey placenta. J Biochem. 1976 Aug;80(2):389-96. doi: 10.1093/oxfordjournals.jbchem.a131288.
PMID: 12146BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident
Study Record Dates
First Submitted
October 25, 2021
First Posted
November 4, 2021
Study Start
November 1, 2021
Primary Completion
November 1, 2024
Study Completion
March 1, 2025
Last Updated
November 4, 2021
Record last verified: 2021-10